{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T07:53:51Z","timestamp":1777622031293,"version":"3.51.4"},"reference-count":22,"publisher":"Informa Healthcare","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Expert Opinion on Pharmacotherapy"],"published-print":{"date-parts":[[2000,3]]},"DOI":"10.1517\/14656566.1.3.547","type":"journal-article","created":{"date-parts":[[2005,5,4]],"date-time":"2005-05-04T19:29:31Z","timestamp":1115234971000},"page":"547-553","source":"Crossref","is-referenced-by-count":3,"title":["Gemcitabine in the treatment of bladder cancer"],"prefix":"10.1517","volume":"1","author":[{"given":"Christopher W","family":"Ryan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J","family":"Vogelzang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"3197","published-online":{"date-parts":[[2005,2,24]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3322\/canjclin.49.1.8","volume":"49","author":"LANDIS SH","year":"1999","journal-title":"CA Cancer J. Clin."},{"key":"CIT0002","first-page":"2448","volume":"64","author":"STERNBERG CN","year":"1989","journal-title":"Efficacy and patterns of response and relapse. Cancer"},{"key":"CIT0004","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1200\/JCO.1992.10.7.1066","volume":"10","author":"LOEHRER PJ","year":"1992","journal-title":"J. Clin. Oncol"},{"key":"CIT0006","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1200\/JCO.1990.8.6.1050","volume":"8","author":"LOGOTHETIS CJ","year":"1990","journal-title":"J. Clin. Oncol."},{"key":"CIT0008","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1200\/JCO.1985.3.11.1463","volume":"3","author":"HARKER WG","year":"1985","journal-title":"J. Clin. Oncol."},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1200\/JCO.1997.15.7.2564","volume":"15","author":"SAXMAN SB","year":"1997","journal-title":"J. Oncol."},{"key":"CIT0011","first-page":"4417","volume":"50","author":"HERTEL LW","year":"1990","journal-title":"Cancer Res"},{"key":"CIT0012","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1200\/JCO.1991.9.3.491","volume":"9","author":"ABBRUZZESE JL","year":"1991","journal-title":"j Gun. Oncol."},{"key":"CIT0015","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1200\/JCO.1997.15.6.2403","volume":"15","author":"BURRIS HA III, MOORE MJ, ANDERSEN J et al.","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1200\/JCO.1995.13.11.2731","volume":"13","author":"CARMICHAEL J","year":"1995","journal-title":"j Clin. Oncol."},{"key":"CIT0018","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/jnci\/86.20.1530","volume":"86","author":"LUND B","year":"1994","journal-title":"J. Natl. Cancer Inst."},{"key":"CIT0019","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1093\/oxfordjournals.annonc.a058775","volume":"5","author":"POLLERA CF","year":"1994","journal-title":"Ann. Oncol"},{"key":"CIT0020","first-page":"1208","volume":"34","author":"LORUSSO V","year":"1998","journal-title":"Italian Co-operative Group on Bladder Cancer. Eur. J. Cancer"},{"key":"CIT0021","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1200\/JCO.1997.15.12.3441","volume":"15","author":"MOORE MJ","year":"1997","journal-title":"J. Clin. Oncol."},{"key":"CIT0023","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1200\/JCO.1997.15.11.3394","volume":"15","author":"STADLER WM","year":"1997","journal-title":"J. Clin. Oncol"},{"key":"CIT0025","first-page":"16","volume":"23","author":"PETERS GJ","year":"1996","journal-title":"Semin. Oncol"},{"key":"CIT0026","first-page":"A1155","volume":"16","author":"VON DER MAASE H, ANDERSEN L, CRINO L, WEISSBACH L,","year":"1997","journal-title":"Proc. Am. Soc. Clin. Oncol"},{"key":"CIT0027","first-page":"320A","volume":"17","author":"KAUFMAN D","year":"1998","journal-title":"Proc. Am. Soc. Clin. Oncol"},{"key":"CIT0028","doi-asserted-by":"crossref","first-page":"2876","DOI":"10.1200\/JCO.1999.17.9.2876","volume":"17","author":"MOORE MJ","year":"1999","journal-title":"J. Oncol"},{"key":"CIT0030","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1200\/JCO.1994.12.11.2264","volume":"12","author":"ROTH B","year":"1994","journal-title":"J. Clin. Oncol"},{"key":"CIT0032","first-page":"1853","volume":"15","author":"MCCAFFREY JA","year":"1997","journal-title":"MAZUMDAR M etal.: Phase II trial of docetaxel in patients with advanced or metastatic transitional-cell carcinoma. J. Clin. Oncol"},{"key":"CIT0033","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1023\/A:1008286908930","volume":"9","author":"ROTHENBERG ML","year":"1998","journal-title":"Ann. Oncol."}],"container-title":["Expert Opinion on Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1517\/14656566.1.3.547","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,17]],"date-time":"2019-02-17T17:52:38Z","timestamp":1550425958000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/full\/10.1517\/14656566.1.3.547"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,3]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2005,2,24]]},"published-print":{"date-parts":[[2000,3]]}},"alternative-id":["10.1517\/14656566.1.3.547"],"URL":"https:\/\/doi.org\/10.1517\/14656566.1.3.547","relation":{},"ISSN":["1465-6566","1744-7666"],"issn-type":[{"value":"1465-6566","type":"print"},{"value":"1744-7666","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,3]]}}}